AzTrials
AzTrials

Type 1 Diabetes MellitusNCT03333525

Does Protein and Fat Content of Meal Increase Glucose Concentrations

A study testing Calculation of insulin dosages for different meals in people with Type 1 Diabetes Mellitus, run by TC Erciyes University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study investigated the effects of fat protein counting (CFP) in addition to carbohydrate (CARB) counting for calculating prandial insulin dosage on blood glucose profile in patients with type 1 diabetes (T1D) on basal-bolus insulin therapy. Read more about this study

Who is it for?
Ages 16 to 18 years
Conditions the study is for
Type 1 Diabetes Mellitus
What is being tested?
Calculation of insulin dosages for different meals
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
10 Sep 2013to 20 Feb 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Subjects:
  • had Type1 Diabetes for at least 1 years;
  • use multiple dose (basal-bolus) insulin therapy;
  • use fast-acting insulin analogs (lispro, glulisine, and aspart) and basal insulin analogs (detemir, glargine);
  • daily inslin dose ≥0.5 IU/kg/day.

Who cannot join

  • Subjects:
  • had any restrictive food intake disorders (eg celiac disease or food allergy);
  • had any diabetes complications (eg neuropathy, nephropathy or retinopathy);
  • diagnosed for <1 year;
  • were using corticosteroid or any medication that could effect gastric emptying;
  • did exercise or had hypoglycemia or ketoacidosis within 24 hour before the test meals;
  • had overweight or obese (BMI z score: ≥ 1SD and ≥ 2SD respectively);
  • had not on follicular or peri-ovulatory phases of their menstrual cycles (for females).

About this study

Official title: Does High-Protein High-Fat Meal Increase Postprandial Glucose Concentrations and Meal-Time Insulin Requirements in Patients With Type 1 Diabetes on Basal-Bolus Insulin Regimen: A Randomized Controlled Trial

The study investigated the effects of fat protein counting (CFP) in addition to carbohydrate (CARB) counting for calculating prandial insulin dosage on blood glucose profile in patients with type 1 diabetes (T1D) on basal-bolus insulin therapy.

Read the detailed description

In this single center, crossover, randomized, controlled study, control meal (SM: standard meal using carbohydrate counting method) and three test meals (HPM: high protein meal using carbohydrate counting method, HPFM-a: high protein-fat meal using carbohydrate counting method and HPFM-b: high protein-fat meal using carbohydrate and fat-protein counting method) were compared on postprandial early (0-120 minutes), late (120-240 minutes) and total (0-240 minutes) glucose response.

Being tested
Calculation of insulin dosages for different meals
Keywords
Fat-protein counting, Type 1 diabetes, Postprandial glucose level
Medical subject headings
Diabetes Mellitus, Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calculation of insulin dosages for different mealsOther

    Calculation of insulin dosages For CARB counting meals using insulin-carbohydrate ratio for dosing mealtime boluses. For fat protein counting meal ICR and additionally fat-protein unit were used for dosing of mealtime boluses.

Study groups in NCT03333525
Study groupRoleWhat they receive
Insulin dose-CARB counting HPM groupExperimentalHPM (high protein meal), contained 36 g protein,17 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30 h) in the hospital. The glycaemic index (GI) of meal was 60.40. The insulin dose for meal was calculated according to the carbohydrate counting (insulin-to-carbohydrate ratio-ICR).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
Receives: Other: Calculation of insulin dosages for different meals
Insulin dose-CARB counting HPFM groupExperimentalHPFM (high protein-high fat meal), contained 36 g protein,30 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30 h) in the hospital The glycaemic index (GI) of meal was 60.40. The insulin dose for meal was calculated according to the carbohydrate counting (insulin-to-carbohydrate ratio-ICR).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
Receives: Other: Calculation of insulin dosages for different meals
Insulin dose-CARB+FPU counting-HPFMExperimentalHPFM (high protein-high fat meal), contained 36 g protein,30 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30 h) in the hospital. The glycaemic index (GI) of meal was 60.40. The insulin dose for meal was calculated according to the carbohydrate counting plus fat-protein counting (insulin-to-carbohydrate ratio-ICR and fat-protein unit-FPU).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
Receives: Other: Calculation of insulin dosages for different meals
Insulin dose-CARB counting SM groupActive comparatorSM (standart meal), contained 24 g protein,17 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30 h) in the hospital. The glycaemic index (GI) of meal was 60.40. The insulin dose for meal was calculated according to the carbohydrate counting (insulin-to-carbohydrate ratio-ICR and fat-protein unit-FPU).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
Receives: Other: Calculation of insulin dosages for different meals

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change Postprandial Glucose Concentrations

    Change from baseline capillary blood glucose values at 240 min after control and test meals consumption.

    Measured: 0-240 minutes

Secondary outcomes (1)
  1. Postprandial insulin need

    Insulin dosage was calculated by FPU (is defined as 100 calories of fat and protein) for HFPM-b meal.

    Measured: [Time Frame: 0-240 minutes]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2017
  2. Study start10 Sep 2013
  3. Primary completion20 Feb 2014
  4. Study completion20 Feb 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03333525
Sponsor's protocol ID
2013/173
Other IDs
KEPAN, ESPEN Travel Grant (36 th)
Status last verified
Oct 2017
First submitted
26 Oct 2017
Last updated
7 Nov 2017
Results posted
No
Individual data sharing
No

Publications

  • Kaya N, Kurtoglu S, Gokmen Ozel H. Does meal-time insulin dosing based on fat-protein counting give positive results in postprandial glycaemic profile after a high protein-fat meal in adolescents with type 1 diabetes: a randomised controlled trial. J Hum Nutr Diet. 2020 Jun;33(3):396-403. doi: 10.1111/jhn.12711. Epub 2019 Oct 24.

    PubMed 31647139

Questions about this trial

What is this clinical trial studying?

A study testing Calculation of insulin dosages for different meals in people with Type 1 Diabetes Mellitus, run by TC Erciyes University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change Postprandial Glucose Concentrations (time frame: 0-240 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03333525, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in